Trials / Completed
CompletedNCT00247429
Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients
Vandral Retard (Venlafaxine Extended Release) in Depressive Syndrome With Anxiety and Painful Symptoms in Elderly Patients. Observational Study in Primary Care
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 59 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
In this study we will assess as a primary objective the effect of venlafaxine retard treatment on primary care attended elderly patients with depressive syndrome. We will also study secondarily its effects on anxiety, somatic and painful symptoms of depression.
Conditions
Timeline
- Start date
- 2004-07-01
- Primary completion
- 2005-10-01
- Completion
- 2005-10-01
- First posted
- 2005-11-01
- Last updated
- 2009-09-01
Source: ClinicalTrials.gov record NCT00247429. Inclusion in this directory is not an endorsement.